VPRB vs TPB vs CIRX Stock Comparison

VPR Brands, Turning Point Brands and Cirtran Prices as of Oct 26, 2026 Peers: Industry group
VPRB VPR Brands, LP.
$0.09 +12.5% 1M +350.0% 1Y
Market cap
$8.26M
P/E
8.2x
Revenue (TTM)
$2.94M
Div. yield
–
Tobacco Consumer Staples
3 wins
CIRX Cirtran Corp
$0.02 -50.0% 1M +100.0% 1Y
Market cap
$98.91K
P/E
0.0x
Revenue (TTM)
$4.83M
Div. yield
–
Tobacco Consumer Staples
3 wins

Head to Head

9 decided of 12

Turning Point Brands leads on 3 of the 12 questions below (Turning Point Brands 3, Cirtran 3, VPR Brands 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionVPRBTPBCIRXLeader
Larger companyMarket capitalisation $8.26M $1.30B $98.91K TPB
Cheaper on earningsLower P/E, profitable companies only 8.2x 29.1x 0.0x CIRX
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 55.8x — –
Faster revenue growthRevenue growth, trailing twelve months -32.5% +24.5% +336.7% CIRX
More profitableNet margin, trailing twelve months 34.1% 8.8% 44.1% CIRX
Better return on capitalReturn on invested capital -50.3% 9.1% — TPB
Less leveragedLower net debt / EBITDA — — 5.6x –
Higher dividend yieldTrailing dividend yield — 0.00% — –
Better 1-year returnPrice return, last 12 months +350.0% -28.4% +100.0% VPRB
Better 5-year returnAnnualised price return, 5 years +17.6%/yr +11.6%/yr -22.2%/yr VPRB
Less volatileAnnualised volatility, 1 year 284.6% 56.5% 294.9% TPB
Higher overall scoreMean of the five percentile scores vs peers 57/100 53/100 51/100 VPRB

Percentile Scorecard

VPRBTPBCIRX

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisVPRBTPBCIRX
Valuation 60 #16 of 38 32 #26 of 38 43 #22 of 38
Growth 32 #24 of 35 50 #18 of 35 94 #3 of 35
Profitability 80 #8 of 36 89 #5 of 36 60 #15 of 36
Financial Health 58 #17 of 39 79 #9 of 39 5 #37 of 39
Shareholder Returns – 17 #11 of 13 –
Overall 57 53 51
  • VPRB ranked among 40 companies in Tobacco and Cannabis
  • TPB ranked among 40 companies in Tobacco and Cannabis
  • CIRX ranked among 40 companies in Tobacco and Cannabis

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodVPRBTPBCIRXSPY
1 month +12.5%+5.3%-50.0% -0.8%
3 months -25.0%-17.0%-33.3% +3.5%
6 months +350.0%-18.2%-33.3% +7.0%
Year to date +200.0%-39.8%-50.0% +12.2%
1 year +350.0%-28.4%+100.0% +13.0%
3 years -43.8%+229.2%0.0% +86.3%
3 years, per year -17.5%+48.8%0.0% +23.1%
5 years +125.0%+72.8%-71.4% +68.6%
5 years, per year +17.6%+11.6%-22.2% +11.0%
10 years -83.6%+423.7%-90.0% +258.0%
10 years, per year -16.6%+18.0%-20.6% +13.6%

Risk

MeasureVPRBTPBCIRXSPY
Volatility, 1Y 284.6%56.5%294.9% 12.7%
Downside volatility, 1Y 457.5%66.2%647.0% 12.7%
Beta vs S&P 500, 1Y -3.040.611.15 1.00
Return / volatility, 1Y 1.23-0.500.34 1.02
Max drawdown, 5Y -90.9%-61.4%-87.5% -25.4%
From 52-week high -30.8%-54.3%-66.7% -1.8%
52-week high $0.13$142.98$0.06 $779.14
52-week low $0.02$55.23$0.01 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleVPRBTPBCIRX
P/E now vs peer median 8.2xmedian 16.5x 29.2xmedian 16.5x 0.0xmedian 16.5x
P/S now vs peer median 2.8xmedian 0.9x 2.6xmedian 0.9x 0.0xmedian 0.9x
EV/EBITDA now vs peer median —median 12.3x —median 12.3x 5.9xmedian 12.3x
P/FCF now vs peer median 5.5xmedian 23.1x 66.7xmedian 23.1x -0.2xmedian 23.1x
P/B now vs peer median 7.4xmedian 1.0x 2.9xmedian 1.0x 0.0xmedian 1.0x
PEG now vs peer median 1.00median 0.56 0.56median 0.56 0.00median 0.56

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsVPRBTPBCIRX
Revenue $2.94M $507.23M $4.83M
Gross profit $737.52K $300.08M $2.27M
Operating income -$1.71M $75.01M $303.56K
Net income $1.00M $59.64M $2.13M
Free cash flow $1.51M $19.63M -$586.50K
EPS (diluted) $0.01 $2.21 $0.43
Cash & equivalents $2.14M $270.20M $158.14K
Total debt $2.40M $1.18B $9.67M
Shares (diluted) 91.75M 20.16M 4.95M
Enterprise value $2.77M $404.34M -$99.43K

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricVPRBTPBCIRX
P/E 8.2x 29.2x 0.0x
P/FCF 5.5x 66.7x -0.2x
P/Operating cash flow 5.5x 40.6x -0.2x
P/S 2.8x 2.6x 0.0x
P/B 7.4x 2.9x 0.0x
P/Tangible book 7.8x 3.4x 0.0x
EV/EBITDA – – 5.9x
EV/EBIT -4.0x 17.8x 8.0x
EV/Revenue 2.3x 2.6x 0.5x
EV/FCF 4.5x 67.9x -4.1x
EV/Operating cash flow 4.5x 41.4x -4.1x
PEG (3Y EPS CAGR) 1.00 0.56 0.00

Growth

14 metrics
MetricVPRBTPBCIRX
Revenue growth (1Y) -32.5% 24.5% 336.7%
Revenue CAGR (3Y) -28.2% 11.1% 60.3%
Gross profit growth (1Y) -38.8% 31.0% 223.8%
Gross profit CAGR (3Y) -33.1% 16.3% 62.2%
Operating income growth (1Y) -12.3% -15.0% 147.0%
Operating income CAGR (3Y) -62.2% 0.3% 35.6%
Net income growth (1Y) 188.4% 23.8% 187.6%
Net income CAGR (3Y) 6.8% 69.6% 49.2%
EPS growth (1Y) 188.4% -7.6% 187.6%
EPS CAGR (3Y) 8.2% 52.4% 49.2%
Operating cash flow growth (1Y) 767.4% -46.5% 14.4%
Operating cash flow CAGR (3Y) 6.5% -14.0% -162.3%
Free cash flow growth (1Y) 767.4% -62.4% 14.4%
Free cash flow CAGR (3Y) 6.5% -24.4% -162.3%

Profitability

14 metrics
MetricVPRBTPBCIRX
Gross margin 25.1% 59.2% 46.9%
EBITDA margin – – 8.6%
Operating margin -58.1% 14.8% 6.3%
Pretax margin 39.2% 13.6% 44.1%
Net margin 34.1% 8.8% 44.1%
FCF margin 51.4% 3.9% -12.1%
Operating cash flow margin 51.4% 6.4% -12.1%
Return on equity 46.4% 14.2% –
Return on assets 16.1% 7.3% -95.4%
Return on invested capital -50.3% 9.1% –
Return on capital employed -105.1% 10.3% –
Asset turnover 0.8x 0.6x 1.9x
Cash conversion (OCF / net income) 1.5x 0.5x -0.3x
Stock comp / revenue – 1.8% –

Financial Health

11 metrics
MetricVPRBTPBCIRX
Debt / assets 21.0% 34.4% 95.6%
Debt / equity 0.6x 0.6x -0.1x
Net debt / EBITDA – – 5.6x
Debt / FCF 0.5x 15.0x -4.2x
Liabilities / assets 66.7% 46.9% 983.2%
Equity / assets 33.3% 53.1% -883.2%
Interest coverage -10.1x 2.7x 0.4x
Current ratio 1.6x 5.7x 0.1x
Quick ratio 1.3x 3.5x 0.0x
Cash ratio 1.0x 3.1x 0.0x
Altman Z-score -1.19 3.77 -39.49

Shareholder Returns

7 metrics
MetricVPRBTPBCIRX
Dividend yield – 0.5% –
Net buyback yield – -12.2% –
Shareholder yield – -11.7% –
Payout ratio (earnings) – 10.2% –
Payout ratio (FCF) – 30.9% –
Dividend growth (1Y) – 15.9% –
Dividend CAGR (3Y) – 11.9% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusVPRBTPBCIRX
Forward P/E – 55.8xFY2026 –
EPS, next fiscal year – $1.17FY2026 –
EPS growth, next FY – -62.4%FY2026 –
EPS growth, the year after – +59.0% –
Revenue, next fiscal year – $597.82MFY2026 –
Revenue growth, next FY – +29.1%FY2026 –
Revenue growth, the year after – +4.7% –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersVPRBTPBCIRX
Held by institutions – 99.9% –
Institutions holding – 231 –
Change in shares held, QoQ – +8.1% –
Institutions buying – 138 –
Institutions selling – 66 –
Buyers to sellers – 2.09 –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

VPRBTPBCIRX
VPRB 1.00 -0.04 -0.01
TPB -0.04 1.00 0.06
CIRX -0.01 0.06 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, VPRB, TPB and CIRX?

Turning Point Brands (TPB) is the largest by market capitalisation: VPR Brands (VPRB) $8.26M, Turning Point Brands (TPB) $1.30B, Cirtran (CIRX) $98.91K.

Which stock is cheaper, VPRB, TPB and CIRX?

Cirtran (CIRX) trades on the lowest price-to-earnings ratio (VPR Brands (VPRB) 8.2x, Turning Point Brands (TPB) 29.1x, Cirtran (CIRX) 0.0x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Cirtran (CIRX) grew revenue fastest over the trailing twelve months: VPR Brands (VPRB) -32.5%, Turning Point Brands (TPB) +24.5%, Cirtran (CIRX) +336.7%.

Which company is more profitable?

Cirtran (CIRX) has the highest net margin (VPR Brands (VPRB) 34.1%, Turning Point Brands (TPB) 8.8%, Cirtran (CIRX) 44.1%). On return on invested capital, Turning Point Brands (TPB) leads (VPR Brands (VPRB) -50.3%, Turning Point Brands (TPB) 9.1%).

Which stock has performed better?

Over the past year VPR Brands (VPRB) returned the most: VPR Brands (VPRB) +350.0%, Turning Point Brands (TPB) -28.4%, Cirtran (CIRX) +100.0%. Over five years, VPR Brands (VPRB) compounded fastest (VPR Brands (VPRB) +17.6%/yr, Turning Point Brands (TPB) +11.6%/yr, Cirtran (CIRX) -22.2%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Turning Point Brands (TPB) 0.00%. VPR Brands (VPRB) and Cirtran (CIRX) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Turning Point Brands (TPB) has been the steadiest (VPR Brands (VPRB) 284.6%, Turning Point Brands (TPB) 56.5%, Cirtran (CIRX) 294.9%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, VPRB, TPB and CIRX?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Turning Point Brands (TPB) leads on 3. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.